Hengehold Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.98M | Sell |
123,873
-89
| -0.1% | -$2.33K | 0.23% | 71 |
|
|
2026
Q1 | $3.48M | Sell |
123,962
-5,256
| -4% | -$140K | 0.3% | 63 |
|
|
2025
Q4 | $3.22M | Sell |
129,218
-4,604
| -3% | -$116K | 0.27% | 65 |
|
|
2025
Q3 | $3.41M | Buy |
133,822
+2,598
| +2% | +$64.1K | 0.29% | 65 |
|
|
2025
Q2 | $3.18M | Buy |
131,224
+3,486
| +3% | +$81.3K | 0.29% | 64 |
|
|
2025
Q1 | $3.24M | Buy |
127,738
+7,892
| +7% | +$207K | 0.31% | 63 |
|
|
2024
Q4 | $3.18M | Buy |
119,846
+2,043
| +2% | +$55.4K | 0.3% | 60 |
|
|
2024
Q3 | $3.41M | Buy |
117,803
+7,303
| +7% | +$213K | 0.32% | 62 |
|
|
2024
Q2 | $3.09M | Sell |
110,500
-5,788
| -5% | -$159K | 0.32% | 61 |
|
|
2024
Q1 | $3.23M | Buy |
116,288
+22,535
| +24% | +$625K | 0.34% | 57 |
|
|
2023
Q4 | $2.7M | Sell |
93,753
-1,828
| -2% | -$55.3K | 0.32% | 57 |
|
|
2023
Q3 | $3.17M | Buy |
95,581
+2,310
| +2% | +$81.7K | 0.41% | 51 |
|
|
2023
Q2 | $3.42M | Sell |
93,271
-686
| -0.7% | -$26.7K | 0.45% | 46 |
|
|
2023
Q1 | $3.83M | Sell |
93,957
-261
| -0.3% | -$11.3K | 0.53% | 41 |
|
|
2022
Q4 | $4.83M | Buy |
94,218
+2,076
| +2% | +$99.5K | 0.67% | 33 |
|
|
2022
Q3 | $4.03M | Buy |
92,142
+350
| +0.4% | +$17K | 0.62% | 30 |
|
|
2022
Q2 | $4.81M | Buy |
91,792
+875
| +1% | +$44.6K | 0.68% | 27 |
|
|
2022
Q1 | $4.71M | Sell |
90,917
-297
| -0.3% | -$15.4K | 0.64% | 27 |
|
|
2021
Q4 | $5.39M | Sell |
91,214
-651
| -0.7% | -$32.3K | 0.66% | 25 |
|
|
2021
Q3 | $3.95M | Sell |
91,865
-1,736
| -2% | -$76.9K | 0.52% | 32 |
|
|
2021
Q2 | $3.67M | Buy |
93,601
+786
| +0.8% | +$30.6K | 0.48% | 33 |
|
|
2021
Q1 | $3.36M | Buy |
92,815
+7,375
| +9% | +$262K | 0.47% | 36 |
|
|
2020
Q4 | $3.15M | Sell |
85,440
-3,150
| -4% | -$116K | 0.47% | 29 |
|
|
2020
Q3 | $3.08M | Buy |
88,590
+145
| +0.2% | +$5.08K | 0.5% | 26 |
|
|
2020
Q2 | $2.74M | Sell |
88,445
-3,690
| -4% | -$125K | 0.49% | 26 |
|
|
2020
Q1 | $2.85M | Sell |
92,135
-2,581
| -3% | -$87.9K | 0.61% | 24 |
|
|
2019
Q4 | $3.52M | Buy |
94,716
+2,732
| +3% | +$97.3K | 0.6% | 22 |
|
|
2019
Q3 | $3.14M | Buy |
91,984
+158
| +0.2% | +$5.75K | 0.58% | 23 |
|
|
2019
Q2 | $3.77M | Buy |
91,826
+5,087
| +6% | +$202K | 0.72% | 23 |
|
|
2019
Q1 | $3.5M | Buy |
86,739
+1,991
| +2% | +$79.7K | 0.82% | 22 |
|
|
2018
Q4 | $3.51M | Sell |
84,748
-328
| -0.4% | -$13.6K | 1.13% | 20 |
|
|
2018
Q3 | $3.56M | Sell |
85,076
-3,591
| -4% | -$138K | 0.89% | 20 |
|
|
2018
Q2 | $3.05M | Buy |
88,667
+11,684
| +15% | +$399K | 0.79% | 24 |
|
|
2018
Q1 | $2.59M | Buy |
76,983
+1,196
| +2% | +$41.1K | 0.68% | 28 |
|
|
2017
Q4 | $2.6M | Buy |
75,787
+238
| +0.3% | +$8.12K | 0.68% | 26 |
|
|
2017
Q3 | $2.56M | Buy |
75,549
+672
| +0.9% | +$21.6K | 0.68% | 26 |
|
|
2017
Q2 | $2.39M | Buy |
74,877
+1,881
| +3% | +$59.3K | 0.67% | 27 |
|
|
2017
Q1 | $2.37M | Buy |
72,996
+4,740
| +7% | +$149K | 0.66% | 30 |
|
|
2016
Q4 | $2.1M | Buy |
68,256
+3,552
| +5% | +$108K | 0.64% | 33 |
|
|
2016
Q3 | $2.08M | Buy |
64,704
+955
| +1% | +$31.9K | 0.66% | 27 |
|
|
2016
Q2 | $2.13M | Buy |
63,749
+651
| +1% | +$20.8K | 0.69% | 25 |
|
|
2016
Q1 | $1.77M | Buy |
63,098
+49,684
| +370% | +$1.42M | 0.57% | 37 |
|
|
2015
Q4 | $411K | Buy |
13,414
+632
| +5% | +$19.9K | 0.15% | 65 |
|
|
2015
Q3 | $381K | Buy |
12,782
+1,116
| +10% | +$35.8K | 0.17% | 63 |
|
|
2015
Q2 | $371K | Sell |
11,666
-623
| -5% | -$20.3K | 0.13% | 56 |
|
|
2015
Q1 | $406K | Hold |
12,289
| – | – | 0.14% | 55 |
|
|
2014
Q4 | $363K | Buy |
12,289
+3,452
| +39% | +$99K | 0.13% | 56 |
|
|
2014
Q3 | $248K | Buy |
8,837
+670
| +8% | +$18.8K | 0.08% | 62 |
|
|
2014
Q2 | $230K | Buy |
8,167
+661
| +9% | +$18.8K | 0.08% | 64 |
|
|
2014
Q1 | $229K | Sell |
7,506
-361
| -5% | -$10.8K | 0.08% | 65 |
|
|
2013
Q4 | $229K | Hold |
7,867
| – | – | 0.08% | 69 |
|
|
2013
Q3 | $214K | Sell |
7,867
-103
| -1% | -$2.8K | 0.09% | 77 |
|
|
2013
Q2 | $212K | Buy |
+7,970
| New | +$220K | 0.09% | 77 |
|
Other funds holding PFE
AIM
SLAM
CWP
Hengehold Capital Management's PFE Position: Q2 2026 in Review
Hengehold Capital Management reduced its Pfizer (PFE) stake by 0.07% in Q2 2026, selling an estimated $2.33K and leaving 123,873 shares worth $2.98M. The position accounts for 0.23% of the portfolio, ranked #71.
Hengehold Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.39M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Hengehold Capital Management held 123,873 shares of Pfizer worth $2.98M as of Q2 2026.
- Hengehold Capital Management sold 89 Pfizer shares in Q2 2026, an estimated $2.33K.
- Pfizer made up 0.23% of Hengehold Capital Management's portfolio in Q2 2026, its #71 holding.
- Hengehold Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Hengehold Capital Management's Pfizer position peaked at $5.39M in Q4 2021.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Hengehold Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.